DaVita stock launched Tuesday after Novo Nordisk unveiled the results of its weight-loss drug in kidney disease patients.

The post Why Dialysis Stocks DaVita, Fresenius Soared On Novo’s Ozempic News appeared first on Investor’s Business Daily.